105 related articles for article (PubMed ID: 4009447)
1. Dose-independent pharmacokinetics of trimethadione and its metabolite in rats.
Tanaka E; Yoshida T; Kuroiwa Y
J Pharm Sci; 1985 Mar; 74(3):340-1. PubMed ID: 4009447
[TBL] [Abstract][Full Text] [Related]
2. A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.
Kobayashi S; Tanaka E; Oguchi K; Yoshida T; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1984 May; 7(5):329-35. PubMed ID: 6470930
[TBL] [Abstract][Full Text] [Related]
3. Effects of allyl alcohol and bromobenzene on trimethadione metabolism in the rat.
Tanaka E; Nakamura T; Misawa S; Yoshida T; Kuroiwa Y
Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):137-51. PubMed ID: 6473897
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetic study of trimethadione and dimethadione for lysis of pancreatic stones.
Noda A; Yamamoto K; Nakanishi Y
Gastroenterol Jpn; 1986 Apr; 21(2):167-71. PubMed ID: 3710055
[TBL] [Abstract][Full Text] [Related]
5. Determination of trimethadione and its metabolite by gas chromatography with flame-thermionic detection and its application to pharmacokinetic studies of the drug in carbon tetrachloride-treated rats.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Chromatogr; 1983 Feb; 272(2):380-4. PubMed ID: 6833435
[No Abstract] [Full Text] [Related]
6. Effects of cimetidine and diethylaminoethyl 2,2-diphenylvalerate HCL (SKF 525-A) on trimethadione metabolism in the rat.
Tanaka E; Misawa S; Kuroiwa Y
J Pharmacobiodyn; 1985 Sep; 8(9):767-72. PubMed ID: 4087136
[TBL] [Abstract][Full Text] [Related]
7. Determination of plasma trimethadione and its metabolite carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug metabolizing capacity.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1981 Dec; 4(12):961-7. PubMed ID: 7341752
[TBL] [Abstract][Full Text] [Related]
8. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and alpha-naphthylisothiocyanate-intoxicated rats.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
Pharmacology; 1982; 25(4):202-9. PubMed ID: 7146085
[TBL] [Abstract][Full Text] [Related]
9. The effects of short-term administration of ibuprofen on trimethadione metabolism and antipyrine metabolite formation in the rat.
Tanaka E; Kobayashi S; Oguchi K; Kuroiwa Y; Yasuhara H
Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):317-20. PubMed ID: 4023417
[TBL] [Abstract][Full Text] [Related]
10. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
J Pharmacobiodyn; 1987 Sep; 10(9):499-502. PubMed ID: 2830397
[TBL] [Abstract][Full Text] [Related]
11. Relationship between trimethadione metabolism and hepatic drug-oxidizing enzyme activities in different animal species.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1983 Jul; 6(7):481-6. PubMed ID: 6644533
[TBL] [Abstract][Full Text] [Related]
12. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and D-galactosamine intoxicated rats.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
Jpn J Pharmacol; 1982 Dec; 32(6):1182-5. PubMed ID: 7161969
[No Abstract] [Full Text] [Related]
13. Effects of cimetidine and ranitidine on trimethadione metabolism in the rat.
Tanaka E; Misawa S
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):461-4. PubMed ID: 3992022
[TBL] [Abstract][Full Text] [Related]
14. Saliva levels of trimethadione and its metabolite as an index of drug metabolizing activity in rats.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1981 Dec; 4(12):922-7. PubMed ID: 7341748
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of trimethadione and its metabolite in rat and human serum by high-performance liquid chromatography.
Tanaka E; Hagino S; Yoshida T; Kuroiwa Y
J Chromatogr; 1984 Jun; 308():393-7. PubMed ID: 6746833
[No Abstract] [Full Text] [Related]
16. Hepatic trimethadione-oxidizing capacity remains normal in patients with extrahepatic cholelithiasis.
Tanaka E; Ishikawa A; Ono A; Takada A; Okamura T; Misawa S
J Pharmacobiodyn; 1986 May; 9(5):506-9. PubMed ID: 3761137
[TBL] [Abstract][Full Text] [Related]
17. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of microsomal function in hepatectomized rat].
Ishikawa A; Tanaka E; Tsuji K; Fukao K; Misawa S; Iwasaki Y
Nihon Geka Gakkai Zasshi; 1987 Mar; 88(3):303-7. PubMed ID: 3600583
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.
Wells PG; Nagai MK; Greco GS
Toxicol Appl Pharmacol; 1989 Mar; 97(3):406-14. PubMed ID: 2609340
[TBL] [Abstract][Full Text] [Related]
20. Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1982 Mar; 5(3):162-71. PubMed ID: 7097483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
